SES AI (SES) Q2 2022 earnings call transcript

Transcript, summary, guidance, and what analysts pressed on.

Length
26 min
Tone
Positive0.65
Analysts
1
Words
3,583
2022 operating cash investment
$70 million and $80 millionfull-year range
2022 capex
$25 million to $35 millionfull-year range
2022 total cash use
$95 million to $115 millionfull-year range
2023 entering liquidity
well over $300 millionexpected
Shanghai production
about 30 of the cells per day100 amp hour cells
Shanghai monthly capacity
a few thousand of the 100 amp hour cells per month
New OEM testing timeline
about a year, a year to 18 monthstypically

Summary

Management framed the quarter as on plan, with strong liquidity and progress toward A-sample development, while commercialization remains several milestones away.

  • 30 cells per day were being produced in Shanghai, deliberately ramped gradually to resolve problems at small scale.
  • Three JDA partners remain the priority, though management is also developing a fourth and potentially fifth OEM relationship.
  • Management said there were no changes to previously outlined 2023 milestones.

Guidance

  • $70M$70 million to $80 million cash investment in operations for full-year 2022
  • $25M$25 million to $35 million capex for full-year 2022
  • $95M$95 million to $115 million total cash use for full-year 2022
  • $300MWell over $300 million liquidity entering 2023
  • End of October: Korean facility expected ready for use
  • Mid-next year: B-sample expected, with modules and packs entering testing
  • Mid-2024: C-sample expected after about a year of B-sample testing

What analysts pressed on

  • 01IRA incentives: management was still studying details but said partners in Korea and China were excited about North American operations.
  • 02Non-EV applications: drones and delivery robots may commercialize faster; management cited cycle life below 300 as potentially suitable.
  • 03Additional OEM testing: new relationships typically take about a year to 18 months, but management declined to give a specific announcement date.
  • 04A-to-B sample transition: management cited cell-level OEM targets across energy density, fast charge, safety, temperature performance, and impedance.
  • 05Commercial manufacturing: larger plants would follow C-sample de-risking and a contract; management said North America was likely but gave no location or investment figure.
  • 06Lithium-metal anode scaling: management is working with partners and expects collaboration or joint-venture announcements in a few months.

Notable disclosures

  • A-sample cells were being produced at about 30 per day despite capacity for a few thousand 100 amp hour cells monthly.
  • Management described commercialization as requiring technology, manufacturing, and supply-chain de-risking plus a B-sample contract.
  • Current Avatar capabilities are more sophisticated for smaller cells than larger automotive cells, where data collection has only recently begun.
  • Management said automotive applications require cycle life above 500, while some drones and robots could use cells below 300.

Risks raised

  • Large-format cell output remains limited, and management is intentionally ramping gradually to address problems before scaling.
  • 2023 R&D spending was not quantified; headcount, cell materials, and Avatar software costs are expected to increase.
  • Commercial manufacturing plants are not yet planned for construction until later sample milestones and a contract are reached.
  • Battery performance still requires improvement across temperature and charging scenarios, cycle life, safety, and manufacturing cost.

Tone: Positive 0.65

Management emphasized strong liquidity, partner engagement, and on-plan milestones, while acknowledging limited current output and substantial technical and manufacturing work ahead.

Who spoke

Company

  • Eric GoldsteinInvestor Relations
  • Unidentified Management
  • Jing NealisChief Financial Officer

Analysts

  • Unidentified AnalystAnalyst, Water Tower Research

Full transcript

Analyst questions are marked with a bar. Timestamps are into the recording.

Prepared remarks

00:00

Good afternoon. Thank you for attending the SES AI Corporation second quarter earnings call. My name is Matt and I will be your moderator for today's call. All lines will be needed during the presentation portion of the call and opportunity for questions and answers at the end. If you would like to ask a question, please press star one on your telephone key to that. I would now like to pass the conference over to our host, Eric Goldstein, Vice President of Investor Relations. Eric, will you go ahead?

00:27

Eric GoldsteinInvestor Relations

Thank you. Hello, everyone, and welcome to our conference call covering our second quarter 2022 results and outlook for the year. Joining me today are Chi Chow Hu, founder and chief executive officer, and Jing Nielis, chief financial officer. We issued a press release just after 4 p. m. today detailing our financial results. You'll find the press release and today's conference call webcast in the Investor Relations section of our website at SES. AI.

Before we get started, this is a reminder that the discussion today may contain forward-looking information or forward-looking statements within the meaning of applicable securities legislation. These statements are based on our predictions and expectations as of today. Such statements involve certain risks, assumptions, and uncertainties, which may cause the company's actual or future results and performance to be materially different from those expressed or implied in these statements.

The risks and uncertainties that could cause our results to differ materially from our current expectations include, but are not limited to, those detailed in our latest earnings release and in our SEC filings. This afternoon, we will review our business as well as results for the quarter.

With that, I'll pass it over to Chi Chow.

02:04

Unidentified Management

Thank you, Eric. Good afternoon, everyone, and thanks for taking the time to join our call. Our second quarter performance was in line with our expectations, and our liquidity is strong. We ended the quarter with over $400 million of cash on our balance sheet and continue to believe this will be sufficient funding to reach commercialization. Jing will provide more insight into our financials later in the call.

It continues to be a very busy and exciting time for our company and the industry. Consumer interest in electric vehicles continues to grow as OEMs are introducing new models at an accelerating pace. Energy prices remain historically high and the charging infrastructure continues to extent. As a result, we believe the need for more energy-dense batteries that can improve range and reduce cost has never been greater and supports our belief that lithium metal is the next big thing in batteries. We remain the only next-gen lithium metal company to have any A-sample Joint Development Agreements with global car makers, and we have three of them in total, one each with General Motors, Hyundai, and Honda. Moreover, we continue to have active dialogues with other OEMs that could potentially lead to additional JDAs.

While we don't make any formal announcements, our batteries are being tested by many OEMs. We are working closely with all our partners to make further improvements to our battery technology, including improvements to performance under a variety of different temperatures and charging scenarios and to lower our manufacturing cost. Our product development efforts continue to be focused on a number of different areas.

First, we need to develop and manufacture large format 50 and 100 MPower cells. We're working on this at Shanghai Giga and SPS Korea. Over the next few quarters, our intention is to provide more details on manufacturing improvements, supply chain initiatives and data on the performance of our cells.

Second, we continue to make advancements in the areas of materials, electrolytes, and coatings to improve cycle life with periodic fast charge and safety of our batteries. We also continue to explore methods of recycling our batteries, particularly for moxylithium, that are cost-effective. Our final figure facility has run back up after being down in April because of COVID-related shutdowns. We are producing and testing our 50 and 100 amp hour cells and sharing the data with our JVA partners.

Additionally, our brand new facility in SCS Korea is almost done. The structure of the building is complete and our manufacturing lines are being installed. We expect this facility to be ready for use by the end of the third quarter. We continue to pursue opportunities in other verticals in addition to automotive. 12-mAh batteries are lighter weight and particularly good at moving things. We believe there are quite attractive opportunities in verticals such as drones and eVitals. We are having discussions with a number of players in those areas and believe there are potentially some very attractive use cases. We hope to provide more details on these initiatives at Betterworld later this year, including your product demonstrations.

Finally, there are no changes to the milestones we outlined during our first quarter call in May, we remain confident that by 2023, we will, number one, deliver and optimize A samples for our three JDA partners. Number two, begin to transition from A samples to B samples. And number three, continue to establish supply chains for key materials. I will now pass a call to Jim Nielsa, CFO, who will take us through the financials.

05:46

Jing NealisChief Financial Officer

Thank you, Chi Chow. Good afternoon, everyone. Today, I will color our second quarter financial results and discuss our operating and capital budgets for full year 2022. In the second quarter, our operating expenses were $19.1 million, an increase of $12.5 million from the same period last year. Stock-based compensation expense was $5.5 million in the quarter. Our R&D expenses were $7.2 million for the second quarter of 2022, an increase of $3.7 million from the same period last year. This increase reflects higher personnel costs due to increased headcount to support our lithium metal battery development which includes Hermes our platform for new material development and Apollo our engineering capability for large automotive cells, increase in software development cost related to Avatar, our advanced mind-to-man AI-powered software to monitor battery health, and increase in lab consumables and material supplies.

Our gross R&D spend in the quarter was $11.3 million, which was offset by $4.1 million reimbursable from our JDA partners, which was treated as contra-R&D expenses. Our G&A expenses were $11.9 million for the second quarter of 2022, an increase of $8.8 million from the same period last year. This increase was primarily driven by higher personnel costs to support our operations as a public company, an increase in costs related to external consulting, legal, audit, and accounting services. During the second quarter, we incurred a non-cash gain of $29 million associated with the change in fair value of the sponsor-earn-out liability. As we outlined in our first quarter call, certain trenches of our sponsor earn-off shares are accounted for as a derivative liability measured at fair value based on the price of our common stock at the end of the quarter.

For full year 2022, we continue to expect cash investment in the operation to be in the range of $70 million and $80 million and change from our guidance last quarter. As we focus on eight-sample development with our OEM partners, increased production volume of our large 50 and 100 empower cells, and increased spending for the development of Avatar.

TAPEX in the second quarter was $7.5 million, in line with our expectations entering the quarter. Capital investments during the quarter primarily went to the build-out of our facilities in Asia. We continue to expect total 2022 capex to be in the range of $25 million to $35 million and changed from our initial guidance, which will continue to largely go towards our facilities in Asia.

Looking at liquidity, our balance sheet remains strong. We ended the second quarter of 2022 with cash and cash equivalents of $405 million, which we believe is sufficient funding to get us to commercialization. Our second quarter cash used in operating activities and capital expenditures was approximately $20.8 million. For full year 2022, we continue to expect our total use of cash to be between $95 million and $115 million, which should leave us with well over $300 million of liquidity entering 2023.

With that, I will hand the call back to Eric.

09:46

Eric GoldsteinInvestor Relations

Thanks, Jing. We're going to start today's Q&A with some questions that we've been receiving from investors. The first two are for Qi Chow. Qi Chow, what is the current status of our Shanghai facility? What is our current capacity? How many sales are we making per day? And what kind of data are we sharing with our customers?

10:10

Unidentified Management

So current capacity, we have the capacity to make a few thousand of the 100 amp hour cells per month, but currently we're only making about 30 of the cells per day. And we intentionally do that gradually because we want to solve all the problems and then make sure we solve the problems at small scale and then not have a larger scale problem. And we have started collecting data, cycle life with slow charge, cycle life with fast charge, cycle life with periodic fast charge, high temperature, safety, beginning of life, middle of life, end of life, different rates. And then we have started sharing those data with our JDA OEM partners. We also plan to publish some of these data later this year.

11:05

Eric GoldsteinInvestor Relations

Great. question for Chi Chow. Can you talk in a little bit more detail about the development of Avatar? What are our internal developments focused on? And have we done much new hiring in this area?

11:25

Unidentified Management

Sure. So it has two parts. One is the manufacturing data. We have installed sensors in the Shanghai and also the Korea line, the lines for the 50 and the 100 and power cells. And then we use these sensors to collect data. And we try to collect as many of the manufacturing defects as possible. And then second part is we're also building a model on the cell, both physics-based and machine learning-based model so that we can actually use these data, the manufacturing data as well as the performance data. and we use that to train the model. And the goal is to develop the ability to monitor state of health. And because we have much more data on the smaller cells, because we accumulated for many more years, and then we just started doing this for the larger cells, our current avatar is much more sophisticated for the smaller cell than it is for the larger cell.

But that shows the potential for avatar for the larger cells. And yes, we have been hiring a lot in this area.

12:40

Eric GoldsteinInvestor Relations

Okay, great. For Jing, Jing, our capital spending year to date has been $10 million, and our new Korean facility will be ready to use by October. Can you give us a sense for some of the things that we'll be spending on during the balance of this year?

13:02

Jing NealisChief Financial Officer

Thanks, Eric. Yeah so we will finish the build out of our facility in SES Korea and it will be ready to use by the end of October for one of our JDA partners In addition we are planning to further expand this facility to support another one of our JDA partners. Also, we will continue to build phase two of our Shanghai GIGA and add additional manufacturing line for us to serve multiple OEMs and do our internal development work as well as perform cell testing for avatar out of our Shanghai facility okay thank you Matt I think we're now ready for Q&A can you please open the lines for questions certainly if you'd like to ask a question please press star followed by one on your telephone keypad if for any reason you would like to remove that question please press star followed by two Again, to ask a question, press star 1.

Questions and answers

14:07

As a reminder, if you are using a speakerphone, please remember to pick up your handset before asking your question. We will pause here briefly as questions are registered. The first question is from the line of Sean Severson with Water Tower Research. Your line is now open.

14:24

Unidentified AnalystAnalyst, Water Tower Research

SEAN SEVERSON SEVERSON, Great. Thanks for taking my question, guys. Xichao, my first question is regarding the Equation Reduction Act. I know there was some language in there regarding percentage of battery material value, you know, extracted in the U. S. or by a partner country, and also could be recycled as well. But just overall thoughts on that, how you're fitting into that, whether it's a positive or negative for you.

14:51

Unidentified Management

Yeah, thanks. And we're still in the process of studying the details of the bill, but in general, it's So it's a really exciting movement. And then, so for us, lithium metal battery is our core. But then also based on this core, we are building this ecosystem that consists of cathode, animal, electrolyte, separator, cell engineering, pack, algorithm, data collection, recycling.

And then this incentive really motivates a lot of mature companies in this space to partner with us even more. And we're overseeing a lot of our partners in Korea and in China now very excited about moving operations to North America. And then so this definitely further supports our goal to not just develop lithium-ion battery, beyond lithium metal batteries, build this entire ecosystem and also sort of copy and paste the mature and highly efficient supply chain that currently exists in China and Korea in North America because at the end of the day, our lithium metal battery will be built using lithium ion process. So we can actually leverage a lot of the very mature process. So it's a really exciting move.

16:25

Unidentified AnalystAnalyst, Water Tower Research

Thanks. My next question is regarding applications outside of vehicles. I know you talked about drones and a couple others. In general, is that commercialization cycle shorter or longer than what you expect in the vehicle side? So in other words, as you start this process, would this move quickly relative to automotive and timeline, or are there some nuances to that that I'm missing here?

16:48

Unidentified Management

Sure. In general we expect the non-EV applications like drones, delivery robots, these applications to definitely move faster than automobiles. It's more fragmented but definitely will happen faster. And then we are, for example, in our development for lithium metal, for example, if the cycle of less than 300, we can definitely use that for drones and robots. And then if we catch more than 500, then that's for automotive. So we do have different thresholds. And while we improve and then get closer to meeting the automotive targets, we can definitely serve these other markets. And we are. And later this year, we will have a better world, our second better world 2022. And then we do plan to do some demos in these other markets, especially drones.

17:44

Unidentified AnalystAnalyst, Water Tower Research

Thanks. My last question, I'll jump back in the queue, is regarding the comment about your testing with additional OEMs. How long does that process take you? I mean, when you say testing before you might announce another agreement or something like that, I mean, we're talking these are 12-month processes, 18-month process. I'm just trying to understand the timeframe when you say testing with additional OEMs.

18:11

Unidentified Management

Yeah. Yeah, so the timeframe typically from, because now we have made a lot of progress with the three JDAs, so when we start with a new OEM, we don't start from the beginning. We start with a more established set of data. So typically it takes about a year, a year to 18 months. And then, of course, our primary goal is to turn one of our three A-sample JTAs into a B-sample. That's the priority. And then, at the same time, we are developing a fourth, potentially fifth OEM JTA.

18:55

Unidentified AnalystAnalyst, Water Tower Research

Great. Thanks for that.

18:58

Thank you. Thank you for your question. There are currently no further questions registered, so as a reminder, if you start one on your telephone keypad. The next question is from the line of David Bell with Wolf Research. Your line is now open.

19:27

Unidentified AnalystAnalyst, Wolfe Research

Hi, guys. Thanks for taking my question. I wanted to quickly ask, could you remind us again of the timeline and specific criteria of transitioning from A sample to B sample? And regarding commercialization can you give us just a little bit more insight on what you need to see or when you will actually need to invest into a production cell facility or would you be able to use your existing entire Korea to supply for the initial programs that you're targeting thank you yeah thanks David the current plan is so now we're in a sample and then we are building these 50 and 100 empire cells and And then we expect to get to B sample next year.

20:15

Unidentified Management

And the criteria is basically at the cell level. These 50 and 100 amp hour cells need to meet the OEM targets for the A sample. There's energy density, cyclical fast charge, rate, safety, high temperature, low temperature impedance, basically a complicated spider chart of specs. And then in mid-next year, we expect to get a B sample. B sample, we will be building modules and packs with these cells and start testing some in a small number of vehicles. And then we expect that to take about a year, so until mid-2024. And then that's when we expect to get a C sample. C sample, we will test basically B sample, but in more vehicles, dozens and even hundreds of vehicles.

So our definition of commercialization is we are basically we've de-risked A sample and B sample. We've de-risked all the technology challenges, all the manufacturing challenges, all the supply chain challenges, and then we receive a contract for B sample and commercial. And that's when we start to build manufacturing plants. Our current facility in Shanghai and Korea are only for A and D sample. They're too small for manufacturing facilities. So once we get a C sample and beyond, we will work with our OEM partners to identify a suitable location and build larger manufacturing sites. And so far, it looks like that will very likely be in North America.

22:02

Unidentified AnalystAnalyst, Wolfe Research

Okay, thanks, Keechao, for that color. And just one additional question here on the supply chain. Is there anything that you could share with us on the scaling of the lithium metal anode? Is that something we should think about as a capital burden for you in the future, or is the investment going to be more from your partners? Thank you.

22:25

Unidentified Management

Yeah, so we are working with a few partners and we disclose publicly TNG Lithium is one of our largest shareholders and Ivanhoe is also one of our largest shareholders. In addition to this year, we are working with a few other partners in Lithium and we expect to make announcements in a few months about collaboration and potentially joint venture to scale up and lower the cost of these white format between looking foil.

22:59

Unidentified AnalystAnalyst, Wolfe Research

Okay. Thanks, Kejau.

23:01

Unidentified Management

Thanks, Tim.

23:02

Thank you. Thank you for your question. The next question is a follow-up from Sean Severson. Your line is now open.

23:16

Unidentified AnalystAnalyst, Water Tower Research

Thanks. I had a question regarding R&D spend and looking into the second half of 2022 and 2023. Can you give us some rough breakouts of where the spend is taking place in Shanghai, Korea, manufacturing? And importantly, I guess, how or if that would change at all in your 2023 spend? I'm just trying to understand where the budget is today and where it will be going next year.

23:45

Jing NealisChief Financial Officer

I'll take that. Thanks, John. So our overall R&D spend, there are a few big baskets. One is headcount costs. So while we ramp up our pilot line facility and hiring more engineers and R&D employees, our headcount costs will grow globally, and that's happening in Shanghai, Korea, as well as U. S. , in all three locations. And then also another big part of R&D expense is materials and lab-related costs. So while we start to make more cells out of our Shanghai and Korea facility, we will be spending more money on the material cost to make the cells, and we are making a few hundred a month, but that number will grow over the course of this year and also next year once the phase two of Shanghai is up and running and then Korea is expanded.

So I would expect the material cost to increase as well as part of the R&D expense. And then also on the software development, as we grow and then spending more cash on developing the software for Avatar and continue the testing work for the Avatar software, that area of spending also will increase. I don't have a specific number for 23, but these are the areas of spending that we expect to go up a little bit more in 2023, also the second half of this year.

25:34

Unidentified AnalystAnalyst, Water Tower Research

Great. Thank you. That was very helpful.

25:40

Thank you for your question. There are no additional questions waiting at this time, so I'll pass the conference over to the management team for any closing remarks.

25:59

Unidentified Management

Yes, thanks for joining in the call and look forward to speaking with everyone during the quarter.

26:10

Thank you. Thank you. That concludes the conference call. Thank you for your participation. You may now disconnect your line.

Other SES AI earnings calls

  • Q2 2025 earnings call

    Management framed SES as evolving from battery-material discovery into an integrated AI, cells and energy-storage platform, with UZ Energy accelerating commercialization.

    Aug 04, 2025Confident0.76
  • Q1 2025 earnings call

    Management framed 2025 as a transition from capital-intensive manufacturing plans toward a scalable, high-margin materials-discovery software and services model.

    Apr 25, 2025Confident0.72
  • Q4 2024 earnings call

    Management framed SES AI’s shift from EV battery development toward an AI-led, capital-light model spanning materials, software, cells and adjacent markets.

    Feb 25, 2025Positive0.65
  • Q3 2024 earnings call

    Management framed commercialization as advancing on three fronts: UAM supply, EV safety validation, and AI-led material discovery, while emphasizing cash discipline.

    Oct 31, 2024Positive0.63
  • Q2 2024 earnings call

    Management reframed SES as an AI-enabled battery platform, arguing AI can speed commercialization while creating licensing and materials-development revenue beyond lithium metal cells.

    Jul 29, 2024Positive0.65
  • Q1 2024 earnings call

    Hyundai will fund the dedicated facility; SES will invest in and operate the line, which management called practice for C-sample and startup production.

    May 03, 2024Positive0.55
  • Q4 2023 earnings call

    Management framed 2024 as an execution year focused on EV B-sample development, initial UAM shipments, and using AI to improve battery safety prediction.

    Feb 26, 2024Positive0.62
  • Q3 2022 earnings call

    About 1,000 large-format cells have been produced in Shanghai since January, but lines remain deliberately slowed to address quality and manufacturing issues.

    Nov 09, 2022Mildly positive0.25

All SES AI transcripts

Done reading? Open SES AI with the chart, filings, and estimates next to this call.

About this transcript

The summary, guidance, analyst focus, and tone are automated and should be checked against the call before being relied on. Names and figures can be misheard. Listen to the replay.